Literature DB >> 9538215

Genomic structures and chromosomal location of p91, a novel murine regulatory receptor family.

Y Yamashita1, D Fukuta, A Tsuji, A Nagabukuro, Y Matsuda, Y Nishikawa, Y Ohyama, H Ohmori, M Ono, T Takai.   

Abstract

Recently, we found a novel murine cell-surface glycoprotein, designated as p91, expressed mainly in myeloid cells such as macrophages and mast cells. The molecule has six immunoglobulin-like extracellular domains, a transmembrane segment, and a cytoplasmic tail containing four immunoreceptor tyrosine-based inhibition motif (ITIM) or ITIM-like sequences, resembling the structural features of human killer-cell inhibitory receptors (KIR). Here we show that p91 comprises a polymorphic gene family, harboring one potent inhibitory-type p91 and at least two other p91 genes. Tyrosine-phosphorylated, but not nonphosphorylated, synthetic peptides matching the third ITIM and the fourth ITIM-like sequences, respectively, found in the cytoplasmic portion of p91A, the sole inhibitory-type p91, were associated with the tyrosine phosphatases, SHP-1 and SHP-2. In addition, the phosphotyrosyl peptide matching the third ITIM sequence also bound the inositol 5-phosphatase, SHIP. These results support the notion that p91A may function as an inhibitory cell-surface molecule against cell activation. The p91 genes were shown to be clustered in the proximal region of mouse chromosome 7, a syntenic position of human chromosome 19 where the genes for the KIR family are found. A human cDNA clone cross-hybridizing to a murine p91 probe was isolated from a human spleen cDNA library, and was found to code for a molecule quite similar to members of the immunoglobulin-like transcript (or ILT) family. The gene was found to be located on human chromosome 19q13.3-13.4. These results establish the existence of a novel set of potent regulatory receptors in mouse and man, similar but different from the KIR family.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9538215     DOI: 10.1093/oxfordjournals.jbchem.a021945

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  14 in total

1.  Inhibition of IgE-mediated mast cell activation by the paired Ig-like receptor PIR-B.

Authors:  T Uehara; M Bléry; D W Kang; C C Chen; L H Ho; G L Gartland; F T Liu; E Vivier; M D Cooper; H Kubagawa
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

2.  Paternal monoallelic expression of the paired immunoglobulin-like receptors PIR-A and PIR-B.

Authors:  C C Chen; V Hurez; J S Brockenbrough; H Kubagawa; M D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

3.  Lyn kinase promotes erythroblast expansion and late-stage development.

Authors:  Vinit G Karur; Clifford A Lowell; Peter Besmer; Valter Agosti; Don M Wojchowski
Journal:  Blood       Date:  2006-05-16       Impact factor: 22.113

4.  Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B.

Authors:  L H Ho; T Uehara; C C Chen; H Kubagawa; M D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

Review 5.  Paired immunoglobulin-like receptors and their MHC class I recognition.

Authors:  Toshiyuki Takai
Journal:  Immunology       Date:  2005-08       Impact factor: 7.397

6.  Expression of PirB protein in intact and injured optic nerve and retina of mice.

Authors:  Xiaofeng Cai; Rongdi Yuan; Zheng Hu; Chunlin Chen; Jun Yu; Zheng Zheng; Jian Ye
Journal:  Neurochem Res       Date:  2011-11-19       Impact factor: 3.996

Review 7.  Modulation of Toll-like receptor activity by leukocyte Ig-like receptors and their effects during bacterial infection.

Authors:  Louise E Pilsbury; Rachel L Allen; Martin Vordermeier
Journal:  Mediators Inflamm       Date:  2010-06-20       Impact factor: 4.711

Review 8.  Role of PIR-B in autoimmune glomerulonephritis.

Authors:  Toshiyuki Takai; Akira Nakamura; Shota Endo
Journal:  J Biomed Biotechnol       Date:  2010-10-04

9.  Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation.

Authors:  Ai Masuda; Akira Nakamura; Tsutomu Maeda; Yuzuru Sakamoto; Toshiyuki Takai
Journal:  J Exp Med       Date:  2007-04-09       Impact factor: 14.307

10.  Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12.

Authors:  Masanori Inui; Yuki Kikuchi; Naoko Aoki; Shota Endo; Tsutomu Maeda; Akiko Sugahara-Tobinai; Shion Fujimura; Akira Nakamura; Atsushi Kumanogoh; Marco Colonna; Toshiyuki Takai
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.